Cargando…

Neutrophil Extracellular Trap (NET)-Mediated Killing of Pseudomonas aeruginosa: Evidence of Acquired Resistance within the CF Airway, Independent of CFTR

The inability of neutrophils to eradicate Pseudomonas aeruginosa within the cystic fibrosis (CF) airway eventually results in chronic infection by the bacteria in nearly 80 percent of patients. Phagocytic killing of P. aeruginosa by CF neutrophils is impaired due to decreased cystic fibrosis transme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Young, Robert L., Malcolm, Kenneth C., Kret, Jennifer E., Caceres, Silvia M., Poch, Katie R., Nichols, David P., Taylor-Cousar, Jennifer L., Saavedra, Milene T., Randell, Scott H., Vasil, Michael L., Burns, Jane L., Moskowitz, Samuel M., Nick, Jerry A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164657/ https://www.ncbi.nlm.nih.gov/pubmed/21909403 http://dx.doi.org/10.1371/journal.pone.0023637

Ejemplares similares

Fertility, Pregnancy and Lactation Considerations for Women with CF in the CFTR Modulator Era
por: Jain, Raksha, et al.
Publicado: (2021)

A survey: Understanding the health and perspectives of people with CF not benefiting from CFTR modulators
por: Kramer‐Golinkoff, Emily, et al.
Publicado: (2022)

Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mutation
por: Pohl, Kerstin, et al.
Publicado: (2018)

Extremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress Syndrome
por: Nick, Jerry A., et al.
Publicado: (2016)

CFTR Modulators: Impact on Fertility, Pregnancy, and Lactation in Women with Cystic Fibrosis
por: Taylor-Cousar, Jennifer L.
Publicado: (2020)

Mycobacterium abscessus Induces a Limited Pattern of Neutrophil Activation That Promotes Pathogen Survival
por: Malcolm, Kenneth C., et al.
Publicado: (2013)

Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease
por: Shteinberg, Michal, et al.
Publicado: (2020)

Comparative effects of CFTR modulators on phagocytic, metabolic and inflammatory profiles of CF and nonCF macrophages
por: Aridgides, Daniel S., et al.
Publicado: (2023)

Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trial
por: Caceres, Silvia M., et al.
Publicado: (2022)

Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy
por: Parks, Quinn M., et al.
Publicado: (2009)

CF Fungal Disease in the Age of CFTR Modulators
por: Bercusson, Amelia, et al.
Publicado: (2021)

Neutrophil killing of Mycobacterium abscessus by intra- and extracellular mechanisms
por: Malcolm, Kenneth C., et al.
Publicado: (2018)

New therapies for people with CF in the CFTR modulator world
por: Wainwright, Claire E
Publicado: (2020)

SERCA2 Regulates Non-CF and CF Airway Epithelial Cell Response to Ozone
por: Ahmad, Shama, et al.
Publicado: (2011)

Deficient Complement Opsonization Impairs Mycobacterium avium Killing by Neutrophils in Cystic Fibrosis
por: Lenhart-Pendergrass, Patricia M., et al.
Publicado: (2023)

Bacteria-Specific Neutrophil Dysfunction Associated with Interferon-Stimulated Gene Expression in the Acute Respiratory Distress Syndrome
por: Malcolm, Kenneth C., et al.
Publicado: (2011)

Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection
por: Clancy, J P, et al.
Publicado: (2013)

Multicenter Intestinal Current Measurements in Rectal Biopsies from CF and Non-CF Subjects to Monitor CFTR Function
por: Clancy, John P., et al.
Publicado: (2013)

Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles
por: Taylor-Cousar, Jennifer L., et al.
Publicado: (2019)

Optimizing Nasal Potential Difference Analysis for CFTR Modulator Development: Assessment of Ivacaftor in CF Subjects with the G551D-CFTR Mutation
por: Rowe, Steven M., et al.
Publicado: (2013)

Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults
por: Kim, Jeeyeon, et al.
Publicado: (2018)

Macrophages from gut-corrected CF mice express human CFTR and lack a pro-inflammatory phenotype
por: Gillan, Jonathan L, et al.
Publicado: (2022)

Transcriptomic analysis of lung development in wildtype and CFTR(−/−) sheep suggests an early inflammatory signature in the CF distal lung
por: Kerschner, Jenny L., et al.
Publicado: (2023)

Phenotypes of CF rabbits generated by CRISPR/Cas9-mediated disruption of the CFTR gene
por: Xu, Jie, et al.
Publicado: (2021)

Nutrient Availability as a Mechanism for Selection of Antibiotic Tolerant Pseudomonas aeruginosa within the CF Airway
por: Hoffman, Lucas R., et al.
Publicado: (2010)

Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design
por: Jain, Raksha, et al.
Publicado: (2022)

Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients
por: Green, Deanna M, et al.
Publicado: (2010)

Two novel and correlated CF-causing insertions in the (TG)mTn tract of the CFTR gene
por: Pierandrei, Silvia, et al.
Publicado: (2019)

Extensive CFTR Gene Analysis Revealed a Higher Occurrence of Cystic Fibrosis Transmembrane Regulator-Related Disorders (CFTR-RD) among CF Carriers
por: Esposito, Maria Valeria, et al.
Publicado: (2020)

Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis
por: Malcolm, Kenneth C., et al.
Publicado: (2022)

What can the CF registry tell us about rare CFTR-mutations? A Belgian study
por: De Wachter, E., et al.
Publicado: (2017)

Does Pseudomonas aeruginosa Colonization Affect Exercise Capacity in CF?
por: Kampouras, Asterios, et al.
Publicado: (2019)

Comparative Metabolomics and Transcriptomics Reveal Multiple Pathways Associated with Polymyxin Killing in Pseudomonas aeruginosa
por: Han, Mei-Ling, et al.
Publicado: (2019)

Potent Killing of Pseudomonas aeruginosa by an Antibody-Antibiotic Conjugate
por: Kajihara, Kimberly K., et al.
Publicado: (2021)

PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa
por: Burr, Lucy D., et al.
Publicado: (2018)

Potential of anti-inflammatory treatment for cystic fibrosis lung disease
por: Taylor-Cousar, Jennifer L, et al.
Publicado: (2010)

(R)-Roscovitine and CFTR modulators enhance killing of multi-drug resistant Burkholderia cenocepacia by cystic fibrosis macrophages
por: Shrestha, Chandra L., et al.
Publicado: (2020)

Demographic characteristics, clinical and laboratory features, and the distribution of pathogenic variants in the CFTR gene in the Cypriot cystic fibrosis (CF) population demonstrate the utility of a national CF patient registry
por: Yiallouros, Panayiotis K., et al.
Publicado: (2021)

The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy
por: Lommatzsch, Sherstin T., et al.
Publicado: (2019)

The B Lymphocyte Differentiation Factor (BAFF) Is Expressed in the Airways of Children with CF and in Lungs of Mice Infected with Pseudomonas aeruginosa
por: Neill, Daniel R., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l2sbb2dhl0rgu8gsvlc9p29bqs